siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.
暂无分享,去创建一个
Raghibul Hasan | S. S. Chauhan | Rinu Sharma | R. Ralhan | Raghibul Hasan | Shyam Singh Chauhan | Rinu Sharma | Ranju Ralhan | S. Chauhan
[1] P. Warne,et al. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.
[2] J. Rincón,et al. Effect of Emdogain on human periodontal fibroblasts in an in vitro wound-healing model. , 2003, Journal of periodontal research.
[3] A. Pozzi,et al. Signaling Pathways Regulating TC21-induced Tumorigenesis* , 2007, Journal of Biological Chemistry.
[4] R. Ralhan,et al. Clinical significance of TC21 overexpression in oral cancer. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[5] P. Crespo,et al. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins , 1999, Oncogene.
[6] G. Malkan,et al. Epidemiology of digestive cancers in India. I. General principles and esophageal cancer. , 1997, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[7] V. Gaborieau,et al. Risk factors of lung cancer in Chandigarh, India. , 2001, The Indian journal of medical research.
[8] C. Der,et al. Involvement of Phosphatidylinositol 3-Kinase, but Not RalGDS, in TC21/R-Ras2-mediated Transformation* , 2002, The Journal of Biological Chemistry.
[9] V. Gajalakshmi,et al. An Independent Survey to Assess Completeness of Registration: Population Based Cancer Registry, Chennai, India. , 2001, Asian Pacific journal of cancer prevention : APJCP.
[10] D. Brenner,et al. Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Vermeulen,et al. Cell cycle and apoptosis , 2003, Cell proliferation.
[12] L. Chan,et al. Small cell carcinoma of the ovary associated with ins(10;5)(p13;q31q13). , 1994, Cancer genetics and cytogenetics.
[13] M. Karadeniz,et al. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population , 2008, Journal of endocrinological investigation.
[14] C. Der,et al. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.
[15] H. Paterson,et al. Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.
[16] B. Yeole,et al. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. , 2004, Asian Pacific journal of cancer prevention : APJCP.
[17] Rinu Sharma,et al. TC21/R-Ras2 Upregulation in Esophageal Tumorigenesis: Potential Diagnostic Implications , 2005, Oncology.
[18] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[19] S. Moss,et al. Lung cancer screening , 2000, Cancer.
[20] Qin He,et al. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-κB signaling pathway , 2002, Oncogene.
[21] R. Montesano,et al. Environmental causes of human cancers. , 2001, European journal of cancer.
[22] H. Brauch,et al. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer. , 2008, Cancer research.
[23] S. Oldham,et al. TC21 and Ras share indistinguishable transforming and differentiating activities , 1999, Oncogene.
[24] B. Wasylyk,et al. Expression of raf oncogenes activates the PEA1 transcription factor motif , 1989, Molecular and cellular biology.
[25] C. Sherr. Cancer Cell Cycles , 1996, Science.
[26] O. Issinger,et al. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. , 2006, International journal of oncology.
[27] S. S. Chauhan,et al. Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells , 2011, PloS one.
[28] S. Lakhani,et al. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. , 1999, Cancer research.
[29] Jian Huang,et al. Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus , 1995, Journal of leukocyte biology.
[30] David R. Kaplan,et al. Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.
[31] K. Barker,et al. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.
[32] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Mahanta,et al. Role of Dietary Habits in the Development of Esophageal Cancer in Assam, the North-Eastern Region of India , 2001, Nutrition and cancer.
[34] Wenjie Zhu,et al. H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis. , 2006, Molecular biology of the cell.
[35] J. Schrader,et al. Ras and relatives--job sharing and networking keep an old family together. , 2002, Experimental hematology.
[36] Shilpi Arora,et al. Identification of differentially expressed genes in oral squamous cell carcinoma , 2005, Molecular carcinogenesis.